Sector
PharmaceuticalsOpen
₹1,351.9Prev. Close
₹1,344.5Turnover(Lac.)
₹5,263.91Day's High
₹1,372.6Day's Low
₹1,32452 Week's High
₹1,755.952 Week's Low
₹1,052Book Value
₹275.89Face Value
₹1Mkt Cap (₹ Cr.)
33,785.79P/E
40.58EPS
32.87Divi. Yield
0.317 Jul 2024
12:00 AM
AGM
Announcement Date: 17 Jul, 2024
14 Nov 2024
12:00 AM
Dividend
Dividend Amount: 2
Record Date: 27 Nov, 2024
14 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
This consolidation aims to streamline all of Ipca Group's US generics formulations under a single entity, enhancing operational efficiency.
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 25.37 | 25.37 | 25.37 | 25.37 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 6,323.34 | 5,851.93 | 5,450.39 | 4,727.35 |
Net Worth | 6,348.71 | 5,877.3 | 5,475.76 | 4,752.72 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 5,399.36 | 5,139.16 | 4,337.82 | 3,193.4 |
yoy growth (%) | 5.06 | 18.47 | 35.83 | 2.93 |
Raw materials | -1,763.12 | -1,582.48 | -1,480.7 | -1,112.48 |
As % of sales | 32.65 | 30.79 | 34.13 | 34.83 |
Employee costs | -1,089.63 | -948.84 | -870.79 | -712.78 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 1,088.36 | 1,379.96 | 784.97 | 282.8 |
Depreciation | -204.1 | -187.72 | -178.69 | -174.36 |
Tax paid | -217.42 | -239.19 | -132.51 | -49.69 |
Working capital | 484.48 | 421.93 | 376.59 | 222.97 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 5.06 | 18.47 | 35.83 | 2.93 |
Op profit growth | -17.84 | 65.46 | 107.12 | 2.25 |
EBIT growth | -21.07 | 73.34 | 160.98 | 8.97 |
Net profit growth | -23.65 | 74.84 | 179.89 | 23.8 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 8,939.59 | 7,705.04 | 6,244.32 | 5,829.79 | 5,419.99 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 8,939.59 | 7,705.04 | 6,244.32 | 5,829.79 | 5,419.99 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 92.8 | 124.77 | 125.62 | 66.57 | 62.84 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Chairman
Premchand Godha
Managing Director & CFO
A K Jain
Managing Director & CEO
Pranay Godha
Executive Director
Prashant Godha
Independent Non Exe. Director
Kamal Kishore Seth
Independent Non Exe. Director
Narendra Mairpady
Company Sec. & Compli. Officer
Harish P Kamath
Independent Director
Swati Patankar
Independent Director
Vivek Shiralkar
48 Kandivli Industrial Estate,
Kandivli (West),
Maharashtra - 400067
Tel: 91-22-66474444
Website: http://www.ipca.com
Email: [email protected] ; [email protected]
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: [email protected]
Summary
Ipca Laboratories Limited (IPCA) was incorporated on 19th October, 1949 under the name of The Indian Pharmaceutical Combine Association Limited. Ipca is a fully integrated, pharmaceutical company manu...
Read More
Reports by Ipca Laboratories Ltd
What is the Ipca Laboratories Ltd share price today?
What is the Market Cap of Ipca Laboratories Ltd?
What is the PE and PB ratio of Ipca Laboratories Ltd?
What is the 52 Week High and Low of Ipca Laboratories Ltd?
What is the CAGR of Ipca Laboratories Ltd?
What is the shareholding pattern of Ipca Laboratories Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
